View Press Releases
-
Prime Global and Raremark form strategic partnership to transform solutions and outcomes for patients with rare diseases
Medical communications company, Prime Global, and healthcare technology company, Raremark®, announced today that they have formed a strategic partnership to transform solutions for patients with rare diseases. Together, the companies will uncover insights into the entire patient journey that will allow the creation of truly patient-centric drug development and commercialisation programs. Focusing on the needs of patients is the key to powerful communications that make a tangible difference to patient outcomes.
Jan 20, 2021
-
CluePoints’ Risk-Based Quality Management Platform Instrumental in Data Quality Oversight of COVID-19 Trials
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that its Risk-Based Quality Management (RBQM) platform has been critical in supporting numerous Pharmaceutical companies and CROs to interrogate data in their global COVID-19 vaccine and antiviral antibody trials to ensure data quality and integrity.
Jan 20, 2021
-
Domainex expands executive team to support ongoing growth
Domainex welcomes David Cronk to the team as its new Chief of Staff and promotes long standing team member and previous Head of Chemistry, Dr Ray Boffey, to Executive Director of Medicines Research.
Jan 20, 2021
-
PhenoTips® launches Pre-Visit Patient Questionnaires that automatically generate pedigrees using patient-entered data
PhenoTips, creator of the world’s first complete Genomic Health Record™, has launched a digital tool that automatically generates pedigrees from patient-entered information. Pre-Visit Patient Questionnaires are delivered virtually to patients, building pedigrees and patient records in advance of a patient’s initial consultation, which improves the appointment efficiency by over 50% due to the elimination of manual data entry.
Jan 20, 2021
-
Bally Ribbon Mills Manufacturing Materials to Ensure Health and Safety of Front-Line Workers
The press release announces Bally Ribbon Mills continues to focus on producing its line of narrow woven structural tapes and elastics, as well as safety webbing, to protect front-line workers responding to the current global health crisis.
Jan 20, 2021
-
Alfa Chemistry Recently Launched a Sub-website for Functional Polymers
Alfa Chemistry announced the launch of a new sub-website for the supply of functional polymers, including Adsorptive Polymers, Biomedical Polymers, Electrofunctional Polymers, Functional PEGs, Photoactive Polymers, Silicone Polymers and more.
Jan 20, 2021
-
CD BioSciences Reveals Its Capabilities in Conducting Proof of Concept Research
CD BioSciences, a professional US provider of integrated solutions for clinical trials development, has revealed its capabilities of conducting Proof of Concept (PoC) studies and pivotal clinical research for drug development scientists in biological and pharmaceutical institutes and companies.
Jan 26, 2021
-
Alfa Chemistry Announced to Supply Derivatization Reagents for Analytical Testing Scenarios
Earlier this month, Alfa Chemistry announces in a recent statement that the company is starting to provide derivatization reagents of all kinds for customers across the globe. With all the previously released products added together, now the company offers analytical reagents, analytical standards, chromatography standards, and derivatization reagents. In the near future, Alfa Chemistry will continue to add more reagents to meet the increasing demand arising from analytical testing scenarios.
Jan 26, 2021
-
MedAI Launches Artificial Intelligence Drug Discovery (AIDD) Platform to Accelerate Drug Development
To accelerate drug development, MedAI, an expert of AI-assisted R&D research company, announces that it has completed the construction of its Artificial Intelligence Drug Discovery (AIDD) Platform. With this platform, scientists at MedAI are now capable of providing innovative solutions for pharmaceutical companies to push forward their drug discovery projects.
Jan 26, 2021
-
Thermo Fisher Scientific Releases SARS-CoV-2 Optimized Precipitation Reagent* and Enrichment Kits* for Isolating Virus Particles
-
Solentim sets new standards in productivity with the launch of ICON™ and STUDIUS™; accelerating assurance rich workflows in the development of new biologics
Solentim launches two new solutions to enhance the development of therapeutic antibodies. ICON™ is a benchtop system for the rapid stratification of high productivity clones and STUDIUS™ is a proprietary software platform that delivers unparalleled data on each cell’s journey through cell line development.
Jan 26, 2021
-
Certa Sine pump makes transporting high-viscosity 3D printing materials easy
Innovative German dental materials manufacturer relies on Certa pump technology to transport high-viscosity 3D printing materials.
Jan 26, 2021
-
Parent Project Muscular Dystrophy’s Duchenne Registry Participant Response Rate Increases Exponentially in 2020 Utilizing THREAD
Year one of The Duchenne Registry powered by THREAD’s decentralized platform sees uptick in survey completion, data collection, and community engagement.
Jan 25, 2021
-
Vaccine Pods Launches from Stealth to Help Eradicate COVID and Announces Collaboration with Stirling Ultracold for its Vaccine Freezers
Vaccine Pods’ industry-first technology, powered by HCI Energy, boosts capacity and power for ultra-low temperature cold chain storage, enabling organizations to safely store and deliver COVID vaccines
Jan 26, 2021
-
Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform
Domainex Ltd. has invested in the WAVEdelta instrument from Creoptix AG. This instrument utilizes Grating-Coupled Interferometry to measure target binding and achieves superior resolution to traditional Surface Plasmon Resonance.
Jan 11, 2021
-
EXTENSIVE LINE OF LIQUID STABLE & READY-TO-USE CLINICAL REFERENCE MATERIALS AVAILABLE FROM VERICHEM LABORATORIES
VERICHEM LABORATORIES has announced the availability of an extensive line of ready-to-use, liquid stable Clinical Reference Materials intended intended for the calibration and calibration verification of clinical testing systems.
Jan 12, 2021
-
Abzena announces opening of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors
-
Kyruus Enables Online Scheduling for COVID-19 Vaccine Visits and Facilitates More Than 100,000 Appointments in the First Month
-
MedAI: Explore Therapeutic Antibody Discovery and Development for Disease Treatment
-
Organocatalysts Available at Alfa Chemistry Catalysts: High Quality and Cost-Effective